Skip to content

RePlus® Implant 705711Recalls & reported problems

Implant Direct Sybron Manufacturing LLC · 5.7mmD x 11.5mmL, 5.0mmD Platform · Class 2 · Implant

All models of RePlus Implant (16)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10841307104353), received between Nov 25, 2020 and Nov 25, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Failure to Osseointegrate” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Failure to Osseointegrate1

Patient problems

  • Failure of Implant1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 25, 2020Failure to Osseointegrate; Failure to Osseointegrate

    PER COMPLAINT (B)(4), AFTER CLINICAL PROCEDURE, PATIENT EXPERIENCED LOSS OF IMPLANT TO OSSEOINTEGRATE.

    Patient problems: Failure of Implant

    MAUDE report 10904137 ↗

Other Implant, Endosseous, Root-Form devices

All Implant, Endosseous, Root-Form devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page